Agenda Unveiled: Inaugural China Bio-Computing Conference Set to Convene, with Over 100 Academicians and Experts Shaping the Future of the Industry!
The First China Bio-Computing Conference, co-hosted by Biotope and Bohe Innovation, will be held at the Suzhou International Expo Center on May 10–11, 2021. The event aims to unite partners from the biotechnology and information technology (BT & IT) industries to jointly build a multi-party integrated industrial ecosystem, achieving comprehensive AI empowerment in the field of biotechnology through information exchange and resource sharing.
The conference will invite over 100 industry scientists, opinion leaders, senior government officials, and corporate partners from the field of biological computing to jointly define biological computing from multiple dimensions, including industry needs, drivers, current challenges, and future prospects.
As of now, 5 academicians, 17+ professors, 3+ clinical research experts, and 43+ corporate founders, executives, technical experts, and investors have confirmed their attendance at the inaugural Bio-Computing Conference.
The co-organizers of this conference are the Baihua Association, the New Drug Founders Club, and BiG, under the guidance of the Administrative Committee of Suzhou Industrial Park.
In-Depth Dialogue: A Cross-Disciplinary Integration Model for New Drug Development
Liu Wei: Co-founder & CEO of BioMap
Zhang Lianshan: Vice General Manager of Hengrui Medicine and Head of Global R&D
Yang Qing: Co-CEO of WuXi AppTec
Jiang Zhaoshi: Executive Director, Bioinformatics and Data Science Department, Multinational Pharmaceutical Company
In-Depth Dialogue: A New Paradigm for Translational Medicine Research Driven by Emerging Omics Technologies
Liu Yuwen: Founding Partner of the Mint Angel Fund, Founder of New Nest, Founder of Bohe
Zhang Zemin: Tenured Professor, School of Life Sciences, Peking University; Scientific Advisor, BioBrain
Mao Li: General Manager and Chief Medical Officer of Livzon Biologics; Tenured Professor at The University of Texas MD Anderson Cancer Center
Wu Jianmin: Director, Center for Cancer Bioinformatics, Peking University Cancer Hospital
Roundtable Discussion: High-Throughput Experimental Data—The Foundation of the Bio-Computing Closed Loop
Cai Jiexing: Senior Vice President, WuXi Biologics
Cui Hao: Founder and CEO of Bota Bio
Chen Hao: CEO of INNOVEL
Xia Qiangwei: CEO of Yongdao Zhiyuan
Roundtable Discussion: Multi-omics Data and Clinical Translational Research
Wu Jianmin: Director, Cancer Bioinformatics Center, Peking University Cancer Hospital
Yu Tianwei: Associate Dean and Professor, School of Data Science, The Chinese University of Hong Kong, Shenzhen
Han Da: Researcher, Institute of Molecular Medicine, Shanghai Jiao Tong University School of Medicine
Zhu Xiuxuan: Professor at Harvard Medical School, Director of Jiahui International Cancer Center (proposed invitee)
Roundtable Discussion: Innovations in Data and Computing Platforms in the Era of Bio-Computing |
Zhu Jun: Tenured Professor, Department of Computer Science and Technology, Tsinghua University; Director, Center for Fundamental Theory Research, Institute for Artificial Intelligence, Tsinghua University (proposed invitee)
Li Xiarong: Founder & CEO of Judao Technology
Xie Changyu: Head of the Theory Group, Tencent Quantum Laboratory
Yu Jun: Researcher at the Beijing Institute of Genomics, Chinese Academy of Sciences (former Deputy Director); one of the principal founders of the BGI Research Center (proposed invitee)
Roundtable Discussion: Innovations in the Underlying Architecture of Biological Computing
Ouyang Jian: General Manager, Baidu Intelligent Chips
Sheng Nan: Chief Scientist at Xuehu Technology
Wang Jianxin: Dean of the School of Computer Science and Engineering, Central South University; Professor (tentatively invited)
Chen Yu’ao: Professor at the University of Science and Technology of China (proposed)
Roundtable Discussion: AIDD vs. CADD
Ding Yuanhua: Founder and CEO of Yuanqi Biopharma; formerly Vice President of External R&D Collaborations at Pfizer
Jiang Xuliang: Co-founder of Suozhi Biotechnology; Former Vice President of Viva Biotech
Pei Jianfeng: Researcher at the Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University; Founder of Infinitus Pharma
Zeng Jianyang: Tenured Professor at the Institute for Interdisciplinary Information Sciences, Tsinghua University; Founder & CTO of Suikun Intelligence
Zhu Weiliang: Researcher, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Gong Xinqi: Professor, Institute of Mathematics Sciences, Renmin University of China
Roundtable Discussion: Where Is the Path for AI + Macromolecular Drug Design?
Xu Ting: Chairman and CEO of Alphamab Oncology
Meng Xun: Founder & CEO of Puzhong Discovery
Guo Bingshi: CSO of Innovent Biologics
He Yun: Head of the Antibody Technology Department at Harbour BioMed
He Qi: Co-founder and Chief Operating Officer of Gaocheng Biopharma
Roundtable Discussion: Neoantigen Recognition and Cell Therapy Development
Peng Songming: Founder & CEO of Xinjing Zhiyuan
Sun Minmin: Chairman & CEO, Yi Mufeng
Wang Yi: Founder & CEO of NewCo Bio
Li Jingyu: CSO of BGI Genomics
Mo Fan: Founder & CEO of NewAnjin
Roundtable Discussion: Value Creation in the Bio-Computing Industry
Li Mingxi: Partner at GT Healthcare Capital Partners
Shan Yibing: Senior Scientist at DE Shaw, Independent Investor
Jing Xutian: Managing Director, Wuyuan Capital
Men Shuai: Partner, Mint Angel Fund (Proposed Invitee)
Roundtable Discussion: The Era of Multidimensional Analysis in AI + Medical Imaging
Li Rui: Researcher, Department of Biomedical Engineering, School of Medicine, Tsinghua University; Founder and Chief Scientist, Qingying Huakang
Gong Nanjie: Director of the Intelligent Medical Imaging and Neural Engineering Laboratory at the International Innovation Center, Tsinghua University; President and Co-Founder of Deepwise Healthcare Technology
Zhang Dalei: Co-founder & Chairman of Airdoc
Wu Xiangchen: CEO of Ruiqian Technology
